American Academy of Allergy, Asthma & Immunology (AAAAI) 2026 Annual Meeting

Feb 27 - Mar 2, 2026

  • Title: A Novel Kinin Biomarker Assay for Characterization of Different Types of Bradykinin-Mediated Angioedema
    Presenter: Evangelia Pardali, Ph.D.
    Poster Number: 078
    Date, time: Friday, February 27, 2026, 2:45-3:45 p.m. EST
  • Title: Content Validity of the Angioedema syMptom Rating scAle (AMRA) to Assess Symptoms of Hereditary Angioedema Attacks
    Presenter: Teresa Caballero, M.D., Ph.D.
    Poster Number: 154
    Date, time: Friday, February 27, 2026, 2:45-3:45 p.m. EST
  • Title: Long-Term Prophylactic Treatment with Oral Deucrictibant Improved Health-Related Quality of Life in Participants with Hereditary Angioedema: Final Results of the Phase 2 CHAPTER-1 Open-Label Extension Study
    Presenter: Michael E. Manning, M.D.
    Poster Number: 159
    Date, time: Friday, February 27, 2026, 2:45-3:45 p.m. EST
  • Title: Oral Deucrictibant Immediate-Release Capsule in Treatment of Hereditary Angioedema Attacks: Results of the Phase 3 RAPIDe-3 Study
    Presenter: Marc A. Riedl, M.D., M.S.
    Featured Poster Number: 831
    Date, time: Sunday, March 1, 2026, 3:30-5:00 p.m. EST
  • Title: Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Final Results of the Phase 2 CHAPTER-1 Open-Label Extension Study
    Presenter: John Anderson, M.D.
    Featured Poster Number: 832
    Date, time: Sunday, March 1, 2026, 3:30-5:00 p.m. EST
  • Title: Sustained Therapeutic Exposure with Once-Daily Oral Deucrictibant Extended-Release Tablet for Prophylaxis of Hereditary Angioedema Attacks
    Presenter: Zhi-Yi Zhang, Ph.D.
    Featured Poster Number: 834
    Date, time: Sunday, March 1, 2026, 3:30-5:00 p.m. EST

Supporting Materials